Medical News

RSS

Nucala (mepolizumab) approved for treatment of asthma patients

The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.

5 Nov 2015

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the Federal Register has posted coding and payment information specific to the new Current Procedural Terminology (CPT)® code covering the Transoral Incisionless Fundoplication (TIF®) procedure.

4 Nov 2015

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Market leaders in temperature controlled microscopy, Linkam Scientific Instruments report on the use of their temperature controlled stages applied to CLEM and fluorescence microscopy to assist in endocytic sorting in the School of Biochemistry at the University of Bristol.

From Linkam Scientific Instruments 4 Nov 2015

Perisylvian polymicrogyria gene found

Researchers have identified the genetic basis for bilateral perisylvian polymicrogyria, the most common form of regional polymicrogyria.

4 Nov 2015

Urinary biomarkers for bladder cancer diagnosis fall short of mark

Authors of a meta-analysis question the accuracy of urinary biomarkers for diagnosing the initial incidence or recurrence of bladder cancer.

4 Nov 2015

Sanford Research scientists develop animal model to study neurodegenerative disease

Sanford Research scientists have developed a pig model for a neurodegenerative disease that could help better treat the disorder and other physiological conditions. The findings of the project are published in Human Molecular Genetics.

4 Nov 2015

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

BioFortis today announced that Children's Cancer Institute has licensed Labmatrix, the award-winning precision medicine and biobanking software platform, to support their "Zero Childhood Cancer" program.

4 Nov 2015

ReDy receives CE clearance for third-generation Renal Denervation System

Renal Dynamics' third-generation Renal Denervation System received CE clearance and is now commercially available in Europe for treatment of Resistant Hypertension. The ReDy Renal Denervation System is based on a novel multi-electrode ablation technology that delivers a pre-determined RF ablation set with a single positioning.

4 Nov 2015

Sexual dysfunction prevalent among recent combat veterans

In a recent study of 247 US veterans returning from conflicts in Iraq and Afghanistan, almost 18% screened positive for sexual functioning difficulties. Self-reported sexual dysfunction was most strongly linked with depression, post-traumatic stress disorder, and female sex.

4 Nov 2015

SMU and University of Maryland researchers awarded NIH grant to combat pediatric asthma

A pair of SMU psychology professors working with University of Maryland engineers have been awarded a National Institutes of Health grant in October that will bring nearly $2 million to their joint project to create a wearable device for pediatric asthma patients that helps them avoid asthma triggers.

4 Nov 2015

Researchers track re-emergence of scarlet fever-causing bacteria

An international study led by University of Queensland researchers has tracked the re-emergence of a childhood disease which had largely disappeared over the past 100 years.

4 Nov 2015

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.

4 Nov 2015

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

4 Nov 2015

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Modern patient-directed management is based on optimal, individual medical treatment and holistic personalised patient-centred care. This is certainly true in prostate cancer where most patients are over 60 years of age. They face a negative physical and functional impact from the diagnosis as well as from the treatment with emotional and social challenges.

4 Nov 2015

New network formed to provide area-wide care for lung cancer patients in Northern Germany

The Pius Hospital Oldenburg, the Institute of Haematopathology Hamburg and NEO New Oncology AG announced today the formation of NOWEL, the North-East-West Lung Network.

4 Nov 2015

Cerapedics' i-FACTOR Peptide Enhanced Bone Graft gets FDA approval for use in cervical spine surgery

Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company’s Premarket Approval (PMA) application for i-FACTOR™ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft is the first bone graft to be approved for use in the cervical spine and only the second PMA-approved bone graft in the spine.

4 Nov 2015

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended September 30, 2015, an increase of 39.3 percent over the prior-year period as reported, or 49.1 percent on a currency-neutral basis.

4 Nov 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

Henry Schein's net sales increase 2.4% to $2.7 billion in third quarter 2015

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record third quarter financial results.

4 Nov 2015

New UCLA study looks at primary care medical home in reducing childrens' repeat visits to hospitals

It's a question of major importance to parents, health policy makers and health care professionals — and a focus of national health care quality improvement initiatives. What keeps children from being readmitted to hospitals in the weeks after they're discharged? Previous research on the subject has focused on the role that hospitals play in the equation. But a new study by doctors at UCLA looked at five factors revolving around the primary physician's office.

4 Nov 2015

Medical News

Nucala (mepolizumab) approved for treatment of asthma patients

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Perisylvian polymicrogyria gene found

Urinary biomarkers for bladder cancer diagnosis fall short of mark

Sanford Research scientists develop animal model to study neurodegenerative disease

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

ReDy receives CE clearance for third-generation Renal Denervation System

Sexual dysfunction prevalent among recent combat veterans

SMU and University of Maryland researchers awarded NIH grant to combat pediatric asthma

Researchers track re-emergence of scarlet fever-causing bacteria

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

New network formed to provide area-wide care for lung cancer patients in Northern Germany

Cerapedics' i-FACTOR Peptide Enhanced Bone Graft gets FDA approval for use in cervical spine surgery

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Henry Schein's net sales increase 2.4% to $2.7 billion in third quarter 2015

New UCLA study looks at primary care medical home in reducing childrens' repeat visits to hospitals

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News